Literature DB >> 15496457

Normal biogenesis and cycling of empty synaptic vesicles in dopamine neurons of vesicular monoamine transporter 2 knockout mice.

Benjamin G Croft1, Gabriel D Fortin, Amadou T Corera, Robert H Edwards, Alain Beaudet, Louis-Eric Trudeau, Edward A Fon.   

Abstract

The neuronal isoform of vesicular monoamine transporter, VMAT2, is responsible for packaging dopamine and other monoamines into synaptic vesicles and thereby plays an essential role in dopamine neurotransmission. Dopamine neurons in mice lacking VMAT2 are unable to store or release dopamine from their synaptic vesicles. To determine how VMAT2-mediated filling influences synaptic vesicle morphology and function, we examined dopamine terminals from VMAT2 knockout mice. In contrast to the abnormalities reported in glutamatergic terminals of mice lacking VGLUT1, the corresponding vesicular transporter for glutamate, we found that the ultrastructure of dopamine terminals and synaptic vesicles in VMAT2 knockout mice were indistinguishable from wild type. Using the activity-dependent dyes FM1-43 and FM2-10, we also found that synaptic vesicles in dopamine neurons lacking VMAT2 undergo endocytosis and exocytosis with kinetics identical to those seen in wild-type neurons. Together, these results demonstrate that dopamine synaptic vesicle biogenesis and cycling are independent of vesicle filling with transmitter. By demonstrating that such empty synaptic vesicles can cycle at the nerve terminal, our study suggests that physiological changes in VMAT2 levels or trafficking at the synapse may regulate dopamine release by altering the ratio of fillable-to-empty synaptic vesicles, as both continue to cycle in response to neural activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496457      PMCID: PMC539174          DOI: 10.1091/mbc.e04-07-0559

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  55 in total

1.  Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals.

Authors:  R L Parsons; M A Calupca; L A Merriam; C Prior
Journal:  J Neurophysiol       Date:  1999-06       Impact factor: 2.714

2.  Morphological correlates of functionally defined synaptic vesicle populations.

Authors:  T Schikorski; C F Stevens
Journal:  Nat Neurosci       Date:  2001-04       Impact factor: 24.884

Review 3.  The synaptic vesicle cycle revisited.

Authors:  T C Südhof
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

4.  Quantal release of serotonin.

Authors:  D Bruns; D Riedel; J Klingauf; R Jahn
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

Review 5.  Molecular mechanisms of neurotransmitter release.

Authors:  E A Fon; R H Edwards
Journal:  Muscle Nerve       Date:  2001-05       Impact factor: 3.217

6.  Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.

Authors:  E N Pothos; K E Larsen; D E Krantz; Y Liu; J W Haycock; W Setlik; M D Gershon; R H Edwards; D Sulzer
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

7.  GDNF enhances the synaptic efficacy of dopaminergic neurons in culture.

Authors:  M J Bourque; L E Trudeau
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

8.  Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture.

Authors:  F J Michel; L E Trudeau
Journal:  Neuropharmacology       Date:  2000-07-10       Impact factor: 5.250

Review 9.  Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Authors:  A E Fleckenstein; J W Gibb; G R Hanson
Journal:  Eur J Pharmacol       Date:  2000-10-06       Impact factor: 4.432

10.  An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.

Authors:  C L Waites; A Mehta; P K Tan; G Thomas; R H Edwards; D E Krantz
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

View more
  9 in total

1.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

Review 2.  Synaptic vesicle protein trafficking at the glutamate synapse.

Authors:  M S Santos; H Li; S M Voglmaier
Journal:  Neuroscience       Date:  2008-03-22       Impact factor: 3.590

3.  Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats.

Authors:  Kathy Steece-Collier; Katherine E Soderstrom; Timothy J Collier; Caryl E Sortwell; Eleonora Maries-Lad
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

4.  Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3.

Authors:  Rebecca P Seal; Omar Akil; Eunyoung Yi; Christopher M Weber; Lisa Grant; Jong Yoo; Amanda Clause; Karl Kandler; Jeffrey L Noebels; Elisabeth Glowatzki; Lawrence R Lustig; Robert H Edwards
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

5.  Monitoring synaptic function at the neuromuscular junction of a mouse expressing synaptopHluorin.

Authors:  Lucia Tabares; Rocio Ruiz; Pedro Linares-Clemente; Michael A Gaffield; Guillermo Alvarez de Toledo; Rafael Fernandez-Chacón; William J Betz
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

6.  Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.

Authors:  Heidi Teppola; Jertta-Riina Sarkanen; Tuula O Jalonen; Marja-Leena Linne
Journal:  Neurochem Res       Date:  2015-10-30       Impact factor: 3.996

7.  Striatal dopamine neurotransmission: regulation of release and uptake.

Authors:  David Sulzer; Stephanie J Cragg; Margaret E Rice
Journal:  Basal Ganglia       Date:  2016-08

8.  Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction.

Authors:  Hermann A Rodrigues; Matheus de C Fonseca; Wallace L Camargo; Patrícia M A Lima; Patrícia M Martinelli; Lígia A Naves; Vânia F Prado; Marco A M Prado; Cristina Guatimosim
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  HERV-W Envelope Triggers Abnormal Dopaminergic Neuron Process through DRD2/PP2A/AKT1/GSK3 for Schizophrenia Risk.

Authors:  Qiujin Yan; Xiulin Wu; Ping Zhou; Yan Zhou; Xuhang Li; Zhongchun Liu; Huawei Tan; Wei Yao; Yaru Xia; Fan Zhu
Journal:  Viruses       Date:  2022-01-14       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.